22 Results | Everything | Search

Product TypeClear Filters

Analytical Chemistry (1)

Biochemicals (22)

Amino Acids (1)

Bile Acids (1)

Kinase Inhibitors (22)

Abl Family & Bcr-Abl (3)

CaMKs (3)

EGFR/ErbB/HER Family (1)

FGFR Family (3)

HGFR Family (1)

LTK Family (4)

Neurotrophin Receptor/Trk Family (4)

p38 MAPK (1)

PDGFR Family (6)

RAF (1)

RET (2)

SRC Family (4)

TAM Family (1)

Tec Family (1)

Tie Family (2)

VEGFR Family (5)

Other Non-Receptor Tyrosine Kinases (3)

Other Receptor Tyrosine Kinases (22)

Other Serine/Threonine Kinases (1)

Peptides (1)

Lipids (1)

Natural Products (1)

Small Molecule Modulators (22)

Research AreaClear Filters

Cancer (16)

Cell Biology (8)

Endocrinology & Metabolism (1)

Epigenetics, Transcription, & Translation (1)

Immunology & Inflammation (3)

Neuroscience (1)

ApplicationClear Filters

Mass Spectrometry (1)

Displaying 1 - 22 of 22 Results

Herbimycin A

An inhibitor of tyrosine kinases and Hsp90

CAS No. 70563-58-5

Item No. 15504

Formulation: A yellow lyophilisate

Purity: ≥95%

Antibiotic TAN 420F
NSC 305978

500 µg

$418

Add

2.5 mg

$1,355

Add

PF-06463922

An orally available inhibitor of ALK and ROS1

CAS No. 1454846-35-5

Item No. 18371

Formulation: A crystalline solid

Purity: ≥98%

Lorlatinib

1 mg

$41

Add

5 mg

$99

Add

10 mg

$178

Add

Entrectinib

A pan-Trk, ROS1, and ALK inhibitor

CAS No. 1108743-60-7

Item No. 19476

Formulation: A crystalline solid

Purity: ≥98%

NMS-E628
RXDX-101

1 mg

$40

Add

5 mg

$132

Add

10 mg

$246

Add

ALW-II-41-27

A multi-kinase inhibitor

CAS No. 1186206-79-0

Item No. 25275

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$69

Add

5 mg

$297

Add

10 mg

$525

Add

Ripretinib

A KIT and PDGFRα inhibitor

CAS No. 1442472-39-0

Item No. 33782

Formulation: A solid

Purity: ≥95%

DCC-2618

5 mg

$90

Add

10 mg

$168

Add

25 mg

$328

Add

50 mg

$567

Add

NVP-BHG712

A selective EphB4 kinase inhibitor

CAS No. 940310-85-0

Item No. 18489

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$41

Add

5 mg

$128

Add

10 mg

$196

Add

25 mg

$437

Add

LDN-211904

An EphB3 kinase inhibitor

CAS No. 1198408-78-4

Item No. 20453

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$75

Add

5 mg

$241

Add

Bosutinib-d₈

An internal standard for the quantification of bosutinib

CAS No. 2733145-45-2

Item No. 25460

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₈)

500 µg

$160

Add

1 mg

$304

Add

DDR1-IN-1 (hydrate)

A selective discoidin domain receptor 1 inhibitor

Item No. 18092

Formulation: A crystalline solid

Purity: ≥95%

Discoidin Domain Receptor 1-IN-1

1 mg

$63

Add

5 mg

$139

Add

10 mg

$242

Add

LY2801653

A MET kinase inhibitor

CAS No. 1206799-15-6

Item No. 25978

Formulation: A solid

Purity: ≥98%

Merestinib

1 mg

$69

Add

5 mg

$198

Add

10 mg

$363

Add

50 mg

$983

Add

TPX-0005

A multi-kinase inhibitor

CAS No. 1802220-02-5

Item No. 23397

Formulation: A crystalline solid

Purity: ≥98%

Repotrectinib

1 mg

$36

Add

5 mg

$153

Add

10 mg

$268

Add

25 mg

$587

Add

7rh

A DDR1 inhibitor

CAS No. 1429617-90-2

Item No. 41861

Formulation: A solid

Purity: ≥98%

DDR1-IN-2
DDR1-IN-7rh
DDR1 Inhibitor 2
DDR1 Inhibitor 7rh
Discoidin Domain Receptor-IN-2
Discoidin Domain Receptor 1 Inhibitor 2
Discoidin Domain Receptor 1 Inhibitor 7rh

5 mg

$138

Add

10 mg

$248

Add

25 mg

$516

Add

50 mg

$825

Add

Derazantinib

An inhibitor of FGFR

CAS No. 1234356-69-4

Item No. 27636

Formulation: A crystalline solid

Purity: ≥95%

ARQ 087

1 mg

$65

Add

5 mg

$163

Add

10 mg

$260

Add

25 mg

$488

Add

N-Lithocholyl-L-Alanine

A bile acid conjugate and an EPHA2 inhibitor

CAS No. 1428095-28-6

Item No. 40929

Formulation: A solid

Purity: ≥95%

Alanolithocholic Acid

100 mg

$109

Add

250 mg

$246

Add

500 mg

$464

Add

ASP3026

An ALK inhibitor

CAS No. 1097917-15-1

Item No. 18491

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$43

Add

5 mg

$106

Add

10 mg

$168

Add

25 mg

$365

Add

KYL (trifluoroacetate salt)

An EphA4 inhibitor

Item No. 36911

Formulation: A solid

Purity: ≥95%

KYL Peptide

500 µg

$98

Add

1 mg

$186

Add

5 mg

$490

Add

10 mg

$686

Add

ODM-203

A dual inhibitor of VEGFR and FGFR

CAS No. 1430723-35-5

Item No. 31451

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$134

Add

10 mg

$240

Add

25 mg

$498

Add

50 mg

$795

Add

Sulfatinib

A multi-kinase inhibitor

CAS No. 1308672-74-3

Item No. 34206

Formulation: A solid

Purity: ≥98%

HMPL-012

1 mg

$41

Add

5 mg

$119

Add

10 mg

$178

Add

25 mg

$245

Add

AZ 304

A B-RAF and B-RAF^V600E inhibitor

CAS No. 942507-42-8

Item No. 37580

Formulation: A solid

Purity: ≥95%

1 mg

$40

Add

5 mg

$148

Add

10 mg

$257

Add

25 mg

$541

Add

DDR-TRK-1

A DDR1 inhibitor

CAS No. 1934246-19-1

Item No. 41321

Formulation: A solid

Purity: ≥95%

Discoidin Domain Receptor-TRK-1

1 mg

$43

Add

5 mg

$161

Add

10 mg

$301

Add

Taletrectinib

An ROS1, TrkA, and TrkC inhibitor

CAS No. 1505514-27-1

Item No. 45040

Formulation: A solid

Purity: ≥98%

AB-106
DS-6051b

1 mg

$98

Add

5 mg

$441

Add

10 mg

$735

Add

JI-101

An inhibitor of VEGFR2, PDGFRβ, and EphB4

CAS No. 900573-88-8

Item No. 36405

Formulation: A solid

Purity: ≥98%

CGI1842

1 mg

$32

Add

5 mg

$109

Add

10 mg

$203

Add

25 mg

$271

Add

Displaying 1 - 22 of 22 Results

Cart Subtotal:$0

Product TypeClear Filters

Research AreaClear Filters

ApplicationClear Filters

Formulation: A yellow lyophilisate

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A solid

Purity: ≥99% deuterated forms (d1-d8)

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Formulation: A solid

Purity: ≥95%

Formulation: A solid

Purity: ≥95%

Formulation: A solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Purity: ≥99% deuterated forms (d₁-d₈)